Armenia Delays New EAEU Veterinary Product Rules to 1 September 2031, Extends Old Approvals to 2036

Armenia has extended the transition period for veterinary diagnostic and disinfectant preparations until 31 December 2036, synchronizing the entry into force of key EAEU rules for veterinary preparations to 1 September 2031, and maintaining document exchange capabilities between member states

Armenia extends veterinary product rules to 2036, aligning with EAEU deadlines

The Eurasian Economic Commission has extended Armenia’s transition period for veterinary diagnostic and disinfectant products until 31 December 2036, while synchronising key regulatory deadlines across the Eurasian Economic Union (EAEU) to 1 September 2031. The move preserves document-sharing between member states but delays stricter circulation rules for animal health products by five years. Importers and manufacturers will continue operating under existing national approvals until the new EAEU-wide framework takes effect.

The decision covers four categories of veterinary preparations: diagnostic tools, disinfectants, disinfestation agents, and deacarisational treatments—products used to control parasites in livestock. These fall under a single regulatory umbrella for the first time, replacing overlapping national rules that previously applied different standards to the same product. The change affects hundreds of active ingredients already registered in Armenia, from iodine-based disinfectants to enzyme-linked immunosorbent assay (ELISA) kits for disease detection.

It comes after years of uneven implementation across the EAEU, where some member states had already adopted the new rules while others, including Armenia, lagged behind. The extension gives companies until the end of 2036 to phase out older products that do not meet the updated requirements, though the commission has not specified which ingredients will be banned. Until then, existing registrations remain valid, and importers can continue shipping products approved under Armenia’s current system.

The new deadlines and what they change

The most immediate shift is the synchronised start date for two EAEU-wide regulations: the Rules for regulating the circulation of diagnostic preparations and the Rules for regulating disinfectant, disinfestation and deacarisational preparations. Both were originally set to take effect in 2026 but have now been postponed to 1 September 2031¹. The delay gives manufacturers and importers an additional five years to adapt to the new testing, labelling, and registration requirements.

For diagnostic products—such as rapid test kits for avian influenza or foot-and-mouth disease—the new rules introduce standardised validation protocols. Disinfectants and parasite treatments will face stricter efficacy thresholds, with mandatory third-party testing for claims like "kills 99.9% of bacteria" or "effective against ticks for 30 days". The commission has not yet published the full list of approved active ingredients, but industry groups expect it to mirror the European Union’s biocidal product regulations, which ban several widely used compounds, including certain quaternary ammonium compounds¹.

Until the 2031 deadline, companies can continue using existing registration dossiers, though they must now submit them in both paper and electronic formats to the Eurasian Economic Commission. The commission will maintain this dual system until all EAEU member states fully integrate into the union’s digital information system, which handles processes like cross-border approvals and adverse event reporting¹. Armenia’s veterinary authority has not yet confirmed whether it will adopt the digital system before the 2031 deadline.

Who pays for the transition

The costs of compliance will fall primarily on manufacturers and importers, though the commission has not estimated the financial impact. Companies will need to retest products to meet the new efficacy standards, update labels to include EAEU-specific warnings, and potentially reformulate products that rely on banned ingredients. For small producers, the expense of retesting could exceed the value of their registrations, leading some to discontinue older products rather than upgrade them.

The extension to 2036 applies only to products already on the market, not new submissions. Any product registered after 1 September 2031 must comply with the full EAEU rules from the outset, meaning companies planning to launch new veterinary products in Armenia will need to meet the stricter standards even before the transition period ends. This creates a two-tier system: older products grandfathered in until 2036, and new products subject to immediate compliance.

The commission has not clarified whether Armenia will charge fees for dossier conversions or retesting, but other EAEU members, such as Russia, have introduced levies of up to $5,000 per product for similar transitions. Importers bringing in veterinary products from outside the EAEU—particularly from China, India, and the EU—will face additional scrutiny, as the new rules require all foreign manufacturers to register their production sites with the commission before their products can enter the market¹.

What the extension leaves unchanged

The decision does not alter Armenia’s existing import requirements for veterinary products, which include a pre-shipment certificate from the exporting country’s competent authority and a post-arrival inspection by Armenia’s State Service for Food Safety. These checks remain in place, though the commission has signalled plans to replace them with a single EAEU-wide import permit by 2031. Until then, importers must continue submitting separate documentation to each member state where they sell their products.

The extension also preserves Armenia’s current risk-based classification for veterinary products. Low-risk items, such as alcohol-based hand sanitisers for animal use, remain exempt from registration, while high-risk products, like live diagnostic cultures or genetically modified disinfectants, require full approval. The commission has not indicated whether this risk framework will change under the 2031 rules, but it has proposed harmonising the classification across the EAEU, which could bring stricter controls for some currently exempt products¹.

One area of uncertainty is the fate of products that fail to meet the new standards by 2036. The commission has not specified whether it will grant further extensions or enforce a hard phase-out. Industry groups have called for a grace period for products that are difficult to reformulate, such as certain disinfectants used in poultry farms, where alternatives may not yet exist. The commission has not responded to these requests, leaving companies to plan for the worst-case scenario: a complete ban on non-compliant products after 31 December 2036.

The next steps and what they signal

The draft decision is open for public comments until 13 September 2026, after which the commission will finalise the text¹. The proposed adoption date remains "to be determined," though the commission typically takes three to six months to incorporate feedback. Once adopted, the decision will be published in the EAEU’s official gazette, giving companies a clear timeline to prepare for the 2031 and 2036 deadlines.

The extension reflects broader tensions within the EAEU over regulatory harmonisation. While Armenia has aligned its veterinary rules with the union’s framework, other sectors—such as pharmaceuticals and medical devices—remain subject to national laws that differ significantly from EAEU standards. The veterinary decision sets a precedent for future extensions, suggesting that member states may push for similar delays in other industries where compliance costs are high.

For now, the immediate impact on trade will be limited. The extension gives companies breathing room, but the lack of clarity on banned ingredients and testing protocols means many will begin preparing for the 2031 deadline well in advance. The real test will come in five years, when the new rules take effect—and when products that fail to meet them could disappear from the market overnight.

Sources

1. ↩ Draft Decision of the Council of the Eurasian Economic Commission amending certain decisions of the Council of the Eurasian Economic Commission https://docs.wto.org/imrd/directdoc.asp?DDFDocuments/T/G/TBTN26/ARM111.docx